The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,248 purchase order to Sartorius Corporation for a service agreement and warranty for the IncuCyte S3 system. Under this firm fixed price contract, Sartorius Corporation Division will provide support and maintenance services for the IncuCyte S3 live-cell analysis instrumentation from November 2023 through April 2024 at its Rockville, Maryland location. No subcontractors or set aside designations were identified. The National Cancer Institute supports cancer research to better understand, diagnose, and treat the disease. This contract will help enable continued use of IncuCyte technology to advance such efforts over the performance period.
Generated 12/23/23, 3:59 PM